UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fabrication of New Multifunctional Cotton/Lycra Composites Protective Textiles through Deposition of Nano Silica Coating

Polymers, 2021-08, Vol.13 (17), p.2888

2021

Volltextzugriff (PDF)

Water-free Dyeing of Polyester and Nylon 6 Fabrics with Novel 2-Oxoacetohydrazonoyl Cyanide Derivatives under a Supercritical Carbon Dioxide Medium

Fibers and Polymers, 2018, 19(4), , pp.887-893

2018

Volltextzugriff (PDF)

Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective

Value in health, 2014-11, Vol.17 (7), p.A634-A634

2014

Volltextzugriff (PDF)

Economic Evaluation of Transarterial Chemoembolization With Lipiodol Versus Drug Eluting Bead for the Treatment of Hepatocellular Carcinoma In Egyptian Patients

Value in health, 2015-05, Vol.18 (3), p.A205-A206

2015

Volltextzugriff (PDF)

Budget Impact Analysis of Everolimus Plus Exemestane Versus Gemcitabine Plus Paclitaxel and Capecitabine Plus Docetaxel in Metastatic Breast Cancer Patients in Egypt

Value in health, 2014-11, Vol.17 (7), p.A622-A622

2014

Volltextzugriff (PDF)

EE260 Cost-Effectiveness Analysis of Daratumumab Triplet Therapy Vs Carfilzomib Duplet Therapy in Patients with Relapsed or Refractory Multiple Myeloma in Egypt from Payer Perspective

Value in health, 2023-12, Vol.26 (12), p.S101

2023

Volltextzugriff (PDF)

Economic Evaluation of Lapatinib in Her-2-Positive Metastatic Breast Cancer Patients in Egypt

Value in health, 2014-11, Vol.17 (7), p.A642-A642

2014

Volltextzugriff (PDF)

Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Egyptian Diabetic Patients

Value in health, 2013-11, Vol.16 (7), p.A530-A530

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Sapropterin Versus Phenylalanine Free Diet in Patients with Phenylketonuria in Egypt

Value in health, 2013-11, Vol.16 (7), p.A385-A385

2013

Volltextzugriff (PDF)

CHALLENGES THAT FACE THE APPLICABILITY OF MULTI-INDICATION PRICING FOR INNOVATIVE PRODUCTS IN EGYPT

Value in health, 2016-05, Vol.19 (3), p.A293-A293

2016

Volltextzugriff (PDF)

Cost-Effectiveness of Pazopanib Versus Sunitinib in Egyptian Patients with Metastatic Renal Cell Carcinoma From the Health Insurance Perspective: A Markov Model

Value in health, 2014-05, Vol.17 (3), p.A90-A91

2014

Volltextzugriff (PDF)

PHP72 The Status of Pharmacoeconomic Education in Egyptian Schools of Pharmacy: An Exploratory Analysis

Value in health, 2012-06, Vol.15 (4), p.A26-A26

2012

Volltextzugriff (PDF)

PGI22 - Cost-Effectiveness Analysis of Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in Egypt

Value in health, 2016-11, Vol.19 (7), p.A513-A513

2016

Volltextzugriff (PDF)

PSY85 - Cost Minimization Analysis of Generic Versus Brand Form of Deferasiroix N The Management of B-Thalassemia Patients with Chronic Iron Overload: An Egyptian Health Care Provider Perspective

Value in health, 2016-11, Vol.19 (7), p.A590-A590

2016

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in Egypt

Value in health, 2016-11, Vol.19 (7), p.A513-A513

2016

Volltextzugriff (PDF)

Cost Minimization Analysis of Generic Versus Brand Form of Deferasiroix N The Management of B-Thalassemia Patients with Chronic Iron Overload: An Egyptian Health Care Provider Perspective

Value in health, 2016-11, Vol.19 (7), p.A590-A590

2016

Volltextzugriff (PDF)

HPR207 Moving to Outcomes-Based Agreements in Algeria: Sharing Experiences Between Saudi Arabia and Algeria

Value in health, 2023-12, Vol.26 (12), p.S289

2023

Volltextzugriff (PDF)

HTA341 Egyptian Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Applications

Value in health, 2023-12, Vol.26 (12), p.S386

2023

Volltextzugriff (PDF)

PCN114 - Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective

Value in health, 2014-11, Vol.17 (7), p.A634-A634

2014

Volltextzugriff (PDF)

PGI22 - Economic Evaluation of New HCV Treatments in Egypt

Value in health, 2017-10, Vol.20 (9), p.A635-A635

2017

Volltextzugriff (PDF)

EE288 Economic Evaluation of Generic Tacrolimus and Innovator in Renal Transplant Recipients in Egypt

Value in health, 2022-12, Vol.25 (12), p.S110-S110

2022

Volltextzugriff (PDF)

CO92 Clinician-Reported Outcome Measure for Palonosetron Versus Standard of Care in Chemotherapy-Induced Nausea and Vomiting in Egypt

Value in health, 2023-12, Vol.26 (12), p.S31

2023

Volltextzugriff (PDF)

Economic Evaluation of Lidocaine/Tetracaine Patch Versus Lidocaine/Prilocaine Cream for Topical Anaesthesia Before Vascular Access In Egypt

Value in health, 2015-11, Vol.18 (7), p.A669-A669

2015

Volltextzugriff (PDF)

PSY59 - Economic Evaluation of Lidocaine/Tetracaine Patch Versus Lidocaine/Prilocaine Cream for Topical Anaesthesia Before Vascular Access In Egypt

Value in health, 2015-11, Vol.18 (7), p.A669-A669

2015

Volltextzugriff (PDF)

Economic Evaluation of New HCV Treatments in Egypt

Value in health, 2017-10, Vol.20 (9), p.A635

2017

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fabrication of New Multifunctional Cotton/Lycra Composites Protective Textiles through Deposition of Nano Silica Coating

Water-free Dyeing of Polyester and Nylon 6 Fabrics with Novel 2-Oxoacetohydrazonoyl Cyanide Derivatives under a Supercritical Carbon Dioxide Medium

Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective

Economic Evaluation of Transarterial Chemoembolization With Lipiodol Versus Drug Eluting Bead for the Treatment of Hepatocellular Carcinoma In Egyptian Patients

Budget Impact Analysis of Everolimus Plus Exemestane Versus Gemcitabine Plus Paclitaxel and Capecitabine Plus Docetaxel in Metastatic Breast Cancer Patients in Egypt

EE260 Cost-Effectiveness Analysis of Daratumumab Triplet Therapy Vs Carfilzomib Duplet Therapy in Patients with Relapsed or Refractory Multiple Myeloma in Egypt from Payer Perspective

Economic Evaluation of Lapatinib in Her-2-Positive Metastatic Breast Cancer Patients in Egypt

Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Egyptian Diabetic Patients

Cost-Effectiveness of Sapropterin Versus Phenylalanine Free Diet in Patients with Phenylketonuria in Egypt

CHALLENGES THAT FACE THE APPLICABILITY OF MULTI-INDICATION PRICING FOR INNOVATIVE PRODUCTS IN EGYPT

Cost-Effectiveness of Pazopanib Versus Sunitinib in Egyptian Patients with Metastatic Renal Cell Carcinoma From the Health Insurance Perspective: A Markov Model

PHP72 The Status of Pharmacoeconomic Education in Egyptian Schools of Pharmacy: An Exploratory Analysis

PGI22 - Cost-Effectiveness Analysis of Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in Egypt

PSY85 - Cost Minimization Analysis of Generic Versus Brand Form of Deferasiroix N The Management of B-Thalassemia Patients with Chronic Iron Overload: An Egyptian Health Care Provider Perspective

Cost-Effectiveness Analysis of Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in Egypt

Cost Minimization Analysis of Generic Versus Brand Form of Deferasiroix N The Management of B-Thalassemia Patients with Chronic Iron Overload: An Egyptian Health Care Provider Perspective

HPR207 Moving to Outcomes-Based Agreements in Algeria: Sharing Experiences Between Saudi Arabia and Algeria

HTA341 Egyptian Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Applications

PCN114 - Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective

PGI22 - Economic Evaluation of New HCV Treatments in Egypt

EE288 Economic Evaluation of Generic Tacrolimus and Innovator in Renal Transplant Recipients in Egypt

CO92 Clinician-Reported Outcome Measure for Palonosetron Versus Standard of Care in Chemotherapy-Induced Nausea and Vomiting in Egypt

Economic Evaluation of Lidocaine/Tetracaine Patch Versus Lidocaine/Prilocaine Cream for Topical Anaesthesia Before Vascular Access In Egypt

PSY59 - Economic Evaluation of Lidocaine/Tetracaine Patch Versus Lidocaine/Prilocaine Cream for Topical Anaesthesia Before Vascular Access In Egypt

Economic Evaluation of New HCV Treatments in Egypt

Suchergebnisse filtern